img

Global and India Lanreotide Injection Market Report & Forecast 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global and India Lanreotide Injection Market Report & Forecast 2024-2034

Lanreotide, sold under the brand name Somatuline among others, is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome. It is a long-acting analogue of somatostatin, like octreotide. In the United States and Canada, lanreotide is only indicated for the treatment of acromegaly. In the United Kingdom, it is also indicated in the treatment of thyrotrophic adenoma, a rare tumor of the pituitary gland which secretes TSH. Lanreotide also shows activity against non-endocrine tumors, and, along with other somatostatin analogues, is being studied as a possible general antitumor agent.
Market Analysis and InsightsGlobal and India Lanreotide Injection Market
This report focuses on global and India Lanreotide Injection market, also covers the segmentation data of other regions in regional level and county level.
The global Lanreotide Injection revenue was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period (2024-2034).
In India the Lanreotide Injection revenue is expected to grow from US$ million in 2024 to US$ million by 2034, at a CAGR of % during the forecast period (2024-2034).
The global key players of Lanreotide Injection include Ipsen and Cipla etc. The global five biggest players hold a share of % in 2024.
Global Lanreotide Injection Scope and Market Size
Lanreotide Injection market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Lanreotide Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2034.
For India market, this report focuses on the Lanreotide Injection market size by players, by Type and by Application, for the period 2018-2034. The key players include the global and local players, which play important roles in India.



By Company


Ipsen
Cipla
Segment by Type
Sustained Release Formulation
Long-acting Formula

Segment by Application


Hospital
Clinic
Others
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Lanreotide Injection definition, global sales (volume and revenue), India market size, India percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Lanreotide Injection companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Revenue and volume of Lanreotide Injection in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6Americas by type, by application and by country, sales, and revenue for each segment.
Chapter 7EMEA by type, by application and by region, sales, and revenue for each segment.
Chapter 8China by type, by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, sales, and revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lanreotide Injection sales, revenue, gross margin, and recent development, etc.
Chapter 11Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12Research findings and conclusion

Table of Content

1 Study Coverage
1.1 Lanreotide Injection Product Introduction
1.2 Global Lanreotide Injection Outlook 2018 VS 2024 VS 2034
1.2.1 Global Lanreotide Injection Sales in US$ Million for the Year 2018-2034
1.2.2 Global Lanreotide Injection Sales in Volume for the Year 2018-2034
1.3 India Lanreotide Injection Outlook 2018 VS 2024 VS 2034
1.3.1 India Lanreotide Injection Sales in US$ Million for the Year 2018-2034
1.3.2 India Lanreotide Injection Sales in Volume for the Year 2018-2034
1.4 Lanreotide Injection Market Size, India VS Global, 2018 VS 2024 VS 2034
1.4.1 The Market Share of India Lanreotide Injection in Global, 2018 VS 2024 VS 2034
1.4.2 The Growth Rate of Lanreotide Injection Market Size, India VS Global, 2018 VS 2024 VS 2034
1.5 Lanreotide Injection Market Dynamics
1.5.1 Lanreotide Injection Industry Trends
1.5.2 Lanreotide Injection Market Drivers
1.5.3 Lanreotide Injection Market Challenges
1.5.4 Lanreotide Injection Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Years Considered
2 Lanreotide Injection by Type
2.1 Lanreotide Injection Market Segment by Type
2.1.1 Sustained Release Formulation
2.1.2 Long-acting Formula
2.2 Global Lanreotide Injection Market Size by Type
2.2.1 Global Lanreotide Injection Sales in Value, by Type (2018, 2024 & 2034)
2.2.2 Global Lanreotide Injection Sales in Volume, by Type (2018, 2024 & 2034)
2.2.3 Global Lanreotide Injection Average Selling Price (ASP) by Type (2018, 2024 & 2034)
2.3 India Lanreotide Injection Market Size by Type
2.3.1 India Lanreotide Injection Sales in Value, by Type (2018, 2024 & 2034)
2.3.2 India Lanreotide Injection Sales in Volume, by Type (2018, 2024 & 2034)
2.3.3 India Lanreotide Injection Average Selling Price (ASP) by Type (2018, 2024 & 2034)
3 Lanreotide Injection by Application
3.1 Lanreotide Injection Market Segment by Application
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Others
3.2 Global Lanreotide Injection Market Size by Application
3.2.1 Global Lanreotide Injection Sales in Value, by Application (2018, 2024 & 2034)
3.2.2 Global Lanreotide Injection Sales in Volume, by Application (2018, 2024 & 2034)
3.3.3 Global Lanreotide Injection Average Selling Price (ASP) by Application (2018, 2024 & 2034)
3.3 India Lanreotide Injection Market Size by Application
3.3.1 India Lanreotide Injection Sales in Value, by Application (2018, 2024 & 2034)
3.3.2 India Lanreotide Injection Sales in Volume, by Application (2018, 2024 & 2034)
3.3.3 India Lanreotide Injection Average Selling Price (ASP) by Application (2018, 2024 & 2034)
4 Global Lanreotide Injection Competitor Landscape by Company
4.1 Global Lanreotide Injection Market Size by Company
4.1.1 Global Key Manufacturers of Lanreotide Injection, Ranked by Revenue (2024)
4.1.2 Global Lanreotide Injection Revenue by Manufacturer (2018-2023)
4.1.3 Global Lanreotide Injection Sales by Manufacturer (2018-2023)
4.1.4 Global Lanreotide Injection Price by Manufacturer (2018-2023)
4.2 Global Lanreotide Injection Concentration Ratio (CR)
4.2.1 Lanreotide Injection Market Concentration Ratio (CR)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Lanreotide Injection in 2024
4.2.3 Global Lanreotide Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Lanreotide Injection, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Lanreotide Injection, Product Offered and Application
4.5 Global Key Manufacturers of Lanreotide Injection, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 India Lanreotide Injection Market Size by Company
4.7.1 Key Players of Lanreotide Injection in India, Ranked by Revenue (2024)
4.7.2 India Lanreotide Injection Revenue by Players (2018-2023)
4.7.3 India Lanreotide Injection Sales by Players (2018-2023)
5 Global Lanreotide Injection Market Size by Region
5.1 Global Lanreotide Injection Market Size by Region: 2018 VS 2024 VS 2034
5.2 Global Lanreotide Injection Market Size in Volume by Region (2018-2034)
5.2.1 Global Lanreotide Injection Sales in Volume by Region: 2018-2023
5.2.2 Global Lanreotide Injection Sales in Volume Forecast by Region (2024-2034)
5.3 Global Lanreotide Injection Market Size in Value by Region (2018-2034)
5.3.1 Global Lanreotide Injection Sales in Value by Region: 2018-2023
5.3.2 Global Lanreotide Injection Sales in Value by Region: 2024-2034
6 Americas
6.1 Americas Lanreotide Injection Market Size YoY Growth 2018-2034
6.2 Americas Lanreotide Injection Sales in Volume, by Type (2018, 2024 & 2034)
6.3 Americas Lanreotide Injection Sales in Volume, by Application (2018, 2024 & 2034)
6.4 Americas Lanreotide Injection Market Facts & Figures by Country (2018, 2024 & 2034)
6.4.1 Americas Lanreotide Injection Sales in Value by Country (2018, 2024 & 2034)
6.4.2 Americas Lanreotide Injection Sales in Volume by Country (2018, 2024 & 2034)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Lanreotide Injection Market Size YoY Growth 2018-2034
7.2 EMEA Lanreotide Injection Sales in Volume, by Type (2018, 2024 & 2034)
7.3 EMEA Lanreotide Injection Sales in Volume, by Application (2018, 2024 & 2034)
7.4 EMEA Lanreotide Injection Market Facts & Figures by Country (2018, 2024 & 2034)
7.4.1 EMEA Lanreotide Injection Sales in Value by Country (2018, 2024 & 2034)
7.4.2 EMEA Lanreotide Injection Sales in Volume by Country (2018, 2024 & 2034)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Lanreotide Injection Market Size YoY Growth 2018-2034
8.2 China Lanreotide Injection Sales in Volume, by Type (2018, 2024 & 2034)
8.3 China Lanreotide Injection Sales in Volume, by Application (2018, 2024 & 2034)
9 APAC
9.1 APAC Lanreotide Injection Market Size YoY Growth 2018-2034
9.2 APAC Lanreotide Injection Sales in Volume, by Type (2018, 2024 & 2034)
9.3 APAC Lanreotide Injection Sales in Volume, by Application (2018, 2024 & 2034)
9.4 APAC Lanreotide Injection Market Facts & Figures by Region (2018, 2024 & 2034)
9.4.1 APAC Lanreotide Injection Sales in Value by Region (2018, 2024 & 2034)
9.4.2 APAC Lanreotide Injection Sales in Volume by Region (2018, 2024 & 2034)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 Ipsen
10.1.1 Ipsen Company Information
10.1.2 Ipsen Description and Business Overview
10.1.3 Ipsen Lanreotide Injection Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Ipsen Lanreotide Injection Products Offered
10.1.5 Ipsen Recent Development
10.2 Cipla
10.2.1 Cipla Company Information
10.2.2 Cipla Description and Business Overview
10.2.3 Cipla Lanreotide Injection Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Cipla Lanreotide Injection Products Offered
10.2.5 Cipla Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Lanreotide Injection Industry Chain Analysis
11.2 Lanreotide Injection Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Lanreotide Injection Production Mode & Process
11.4 Lanreotide Injection Sales and Marketing
11.4.1 Lanreotide Injection Sales Channels
11.4.2 Lanreotide Injection Distributors
11.5 Lanreotide Injection Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Figure

List of Tables
Table 1. Lanreotide Injection CAGR in Value, India VS Global, 2018 VS 2024 VS 2034
Table 2. Lanreotide Injection Market Trends
Table 3. Lanreotide Injection Market Drivers
Table 4. Lanreotide Injection Market Challenges
Table 5. Lanreotide Injection Market Restraints
Table 6. Global Lanreotide Injection Sales Growth Rate (CAGR) by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. India Lanreotide Injection Sales Growth Rate (CAGR) by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Lanreotide Injection Sales Growth Rate (CAGR) by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. India Lanreotide Injection Sales Growth Rate (CAGR) by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 10. Global Key Manufacturers of Lanreotide Injection, Ranked by Revenue (2024) & (US$ Million)
Table 11. Global Lanreotide Injection Revenue by Manufacturer, (US$ Million), 2018-2023
Table 12. Global Lanreotide Injection Revenue Share by Manufacturer, 2018-2023
Table 13. Global Lanreotide Injection Sales by Manufacturer, (K Units), 2018-2023
Table 14. Global Lanreotide Injection Sales Share by Manufacturer, 2018-2023
Table 15. Global Lanreotide Injection Price by Manufacturer (2018-2023) & (US$/Unit)
Table 16. Global Lanreotide Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Lanreotide Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lanreotide Injection as of 2024)
Table 18. Global Key Manufacturers of Lanreotide Injection, Manufacturing Base Distribution and Headquarters
Table 19. Global Key Manufacturers of Lanreotide Injection, Product Offered and Application
Table 20. Global Key Manufacturers of Lanreotide Injection, Date of Enter into This Industry
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Key Players of Lanreotide Injection in India, Ranked by Revenue (2024) & (US$ million)
Table 23. India Lanreotide Injection Revenue by Players, (US$ Million), (2018-2023)
Table 24. India Lanreotide Injection Revenue Share by Players, (2018-2023)
Table 25. India Lanreotide Injection Sales by Players, (K Units), (2018-2023)
Table 26. India Lanreotide Injection Sales Share by Players, (2018-2023)
Table 27. Global Lanreotide Injection Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 28. Global Lanreotide Injection Sales in Volume by Region (2018-2023) & (K Units)
Table 29. Global Lanreotide Injection Sales in Volume Forecast by Region (2024-2034) & (K Units)
Table 30. Global Lanreotide Injection Sales in Value by Region (2018-2023) & (US$ Million)
Table 31. Global Lanreotide Injection Sales in Value Forecast by Region (2024-2034) & (US$ Million)
Table 32. Americas Lanreotide Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 33. Americas Lanreotide Injection Sales in Value by Country (2018-2023) & (US$ Million)
Table 34. Americas Lanreotide Injection Sales in Value by Country (2024-2034) & (US$ Million)
Table 35. Americas Lanreotide Injection Sales in Volume by Country (2018-2023) & (K Units)
Table 36. Americas Lanreotide Injection Sales in Volume by Country (2024-2034) & (K Units)
Table 37. EMEA Lanreotide Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 38. EMEA Lanreotide Injection Sales in Value by Country (2018-2023) & (US$ Million)
Table 39. EMEA Lanreotide Injection Sales in Value by Country (2024-2034) & (US$ Million)
Table 40. EMEA Lanreotide Injection Sales in Volume by Country (2018-2023) & (K Units)
Table 41. EMEA Lanreotide Injection Sales in Volume by Country (2024-2034) & (K Units)
Table 42. APAC Lanreotide Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 43. APAC Lanreotide Injection Sales in Value by Country (2018-2023) & (US$ Million)
Table 44. APAC Lanreotide Injection Sales in Value by Country (2024-2034) & (US$ Million)
Table 45. APAC Lanreotide Injection Sales in Volume by Country (2018-2023) & (K Units)
Table 46. APAC Lanreotide Injection Sales in Volume by Country (2024-2034) & (K Units)
Table 47. Ipsen Company Information
Table 48. Ipsen Description and Business Overview
Table 49. Ipsen Lanreotide Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 50. Ipsen Lanreotide Injection Product
Table 51. Ipsen Recent Development
Table 52. Cipla Company Information
Table 53. Cipla Description and Business Overview
Table 54. Cipla Lanreotide Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 55. Cipla Lanreotide Injection Product
Table 56. Cipla Recent Development
Table 57. Key Raw Materials Lists
Table 58. Raw Materials Key Suppliers Lists
Table 59. Lanreotide Injection Customers List
Table 60. Lanreotide Injection Distributors List
Table 61. Research Programs/Design for This Report
Table 62. Key Data Information from Secondary Sources
Table 63. Key Data Information from Primary Sources
List of Figures
Figure 1. Lanreotide Injection Product Picture
Figure 2. Global Lanreotide Injection Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 3. Global Lanreotide Injection Market Size 2018-2034 (US$ Million)
Figure 4. Global Lanreotide Injection Sales 2018-2034 (K Units)
Figure 5. India Lanreotide Injection Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 6. India Lanreotide Injection Market Size 2018-2034 (US$ Million)
Figure 7. India Lanreotide Injection Sales 2018-2034 (K Units)
Figure 8. India Lanreotide Injection Market Share in Global, in Value (US$ Million) 2018-2034
Figure 9. India Lanreotide Injection Market Share in Global, in Volume (K Units) 2018-2034
Figure 10. Lanreotide Injection Report Years Considered
Figure 11. Product Picture of Sustained Release Formulation
Figure 12. Product Picture of Long-acting Formula
Figure 13. Global Lanreotide Injection Market Share by Type in 2024 & 2034
Figure 14. Global Lanreotide Injection Sales in Value by Type (2018-2034) & (US$ Million)
Figure 15. Global Lanreotide Injection Sales Market Share in Value by Type (2018-2034)
Figure 16. Global Lanreotide Injection Sales by Type (2018-2034) & (K Units)
Figure 17. Global Lanreotide Injection Sales Market Share in Volume by Type (2018-2034)
Figure 18. Global Lanreotide Injection Price by Type (2018-2034) & (US$/Unit)
Figure 19. India Lanreotide Injection Market Share by Type in 2024 & 2034
Figure 20. India Lanreotide Injection Sales in Value by Type (2018-2034) & (US$ Million)
Figure 21. India Lanreotide Injection Sales Market Share in Value by Type (2018-2034)
Figure 22. India Lanreotide Injection Sales by Type (2018-2034) & (K Units)
Figure 23. India Lanreotide Injection Sales Market Share in Volume by Type (2018-2034)
Figure 24. India Lanreotide Injection Price by Type (2018-2034) & (US$/Unit)
Figure 25. Product Picture of Hospital
Figure 26. Product Picture of Clinic
Figure 27. Product Picture of Others
Figure 28. Global Lanreotide Injection Market Share by Application in 2024 & 2034
Figure 29. Global Lanreotide Injection Sales in Value by Application (2018-2034) & (US$ Million)
Figure 30. Global Lanreotide Injection Sales Market Share in Value by Application (2018-2034)
Figure 31. Global Lanreotide Injection Sales by Application (2018-2034) & (K Units)
Figure 32. Global Lanreotide Injection Sales Market Share in Volume by Application (2018-2034)
Figure 33. Global Lanreotide Injection Price by Application (2018-2034) & (US$/Unit)
Figure 34. India Lanreotide Injection Market Share by Application in 2024 & 2034
Figure 35. India Lanreotide Injection Sales in Value by Application (2018-2034) & (US$ Million)
Figure 36. India Lanreotide Injection Sales Market Share in Value by Application (2018-2034)
Figure 37. India Lanreotide Injection Sales by Application (2018-2034) & (K Units)
Figure 38. India Lanreotide Injection Sales Market Share in Volume by Application (2018-2034)
Figure 39. India Lanreotide Injection Price by Application (2018-2034) & (US$/Unit)
Figure 40. Americas Lanreotide Injection Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 41. Americas Lanreotide Injection Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 42. Americas Lanreotide Injection Sales by Type (2018-2034) & (K Units)
Figure 43. Americas Lanreotide Injection Sales Market Share in Volume by Type (2018-2034)
Figure 44. Americas Lanreotide Injection Sales by Application (2018-2034) & (K Units)
Figure 45. Americas Lanreotide Injection Sales Market Share in Volume by Application (2018-2034)
Figure 46. United States Lanreotide Injection Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 47. Canada Lanreotide Injection Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 48. Mexico Lanreotide Injection Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 49. Brazil Lanreotide Injection Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 50. EMEA Lanreotide Injection Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 51. EMEA Lanreotide Injection Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 52. EMEA Lanreotide Injection Sales by Type (2018-2034) & (K Units)
Figure 53. EMEA Lanreotide Injection Sales Market Share in Volume by Type (2018-2034)
Figure 54. EMEA Lanreotide Injection Sales by Application (2018-2034) & (K Units)
Figure 55. EMEA Lanreotide Injection Sales Market Share in Volume by Application (2018-2034)
Figure 56. Europe Lanreotide Injection Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 57. Middle East Lanreotide Injection Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 58. Africa Lanreotide Injection Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 59. China Lanreotide Injection Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 60. China Lanreotide Injection Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 61. China Lanreotide Injection Sales by Type (2018-2034) & (K Units)
Figure 62. China Lanreotide Injection Sales Market Share in Volume by Type (2018-2034)
Figure 63. China Lanreotide Injection Sales by Application (2018-2034) & (K Units)
Figure 64. China Lanreotide Injection Sales Market Share in Volume by Application (2018-2034)
Figure 65. APAC Lanreotide Injection Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 66. APAC Lanreotide Injection Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 67. APAC Lanreotide Injection Sales by Type (2018-2034) & (K Units)
Figure 68. APAC Lanreotide Injection Sales Market Share in Volume by Type (2018-2034)
Figure 69. APAC Lanreotide Injection Sales by Application (2018-2034) & (K Units)
Figure 70. APAC Lanreotide Injection Sales Market Share in Volume by Application (2018-2034)
Figure 71. Japan Lanreotide Injection Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 72. South Korea Lanreotide Injection Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 73. China Taiwan Lanreotide Injection Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 74. Southeast Asia Lanreotide Injection Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 75. India Lanreotide Injection Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 76. Lanreotide Injection Value Chain
Figure 77. Lanreotide Injection Production Process
Figure 78. Channels of Distribution
Figure 79. Distributors Profiles
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed